Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria
- PMID: 33088401
- PMCID: PMC7546017
- DOI: 10.11604/pamj.2020.36.272.17827
Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria
Abstract
Introduction: epithelial ovarian cancer (EOC) is the most lethal gynaecological cancer with a recurrence rate as high as 85% after an initial treatment. However, there are currently no reliable means of predicting the risk of recurrence after first-line treatment. This study investigated the risk factors that predict early recurrence of EOC after primary treatment among women in Lagos, Nigeria.
Methods: this was a retrospective cohort study involving the review of all histologically confirmed EOC patients managed at the Lagos University Teaching Hospital, Lagos, Nigeria over a 7-year period from January 2010 to December 2016. A study proforma was used to retrieve relevant information and descriptive statistics were computed for all data. The associations between variables were tested and multivariate analysis was done to adjust for all the possible characteristics that predict early EOC recurrence.
Results: the rate of recurrence of EOC was 76.4%. Suboptimal debulking surgery is the only independent predictor of early tumour recurrence.
Conclusion: women should be adequately counselled and encouraged to report their symptoms early to ensure optimal primary treatment. Strategic efforts should also be made to further improve subspecialty training programs and skills development in gynaecological oncology in Nigeria and sub-Saharan Africa.
Keywords: Cytoreduction; FIGO stage; Lagos; epithelial ovarian cancer; recurrence.
Copyright: Kehinde Sharafadeen Okunade et al.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria.JCO Glob Oncol. 2021 Jan;7:89-98. doi: 10.1200/GO.20.00450. JCO Glob Oncol. 2021. PMID: 33449803 Free PMC article.
-
Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.Niger J Clin Pract. 2020 Aug;23(8):1141-1147. doi: 10.4103/njcp.njcp_134_19. Niger J Clin Pract. 2020. PMID: 32788493 Free PMC article.
-
Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?J Obstet Gynaecol. 2020 Aug;40(6):849-855. doi: 10.1080/01443615.2019.1674264. Epub 2020 Jan 14. J Obstet Gynaecol. 2020. PMID: 31933417
-
[Combining surgery and medical treatments for ovarian cancer: Is there an optimal strategy?].Bull Cancer. 2022 Feb;109(2):197-215. doi: 10.1016/j.bulcan.2021.11.013. Epub 2022 Jan 10. Bull Cancer. 2022. PMID: 35027164 Review. French.
-
[Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):180-186. doi: 10.1016/j.gofs.2018.12.004. Epub 2019 Jan 28. Gynecol Obstet Fertil Senol. 2019. PMID: 30704956 Review. French.
Cited by
-
Impact of obesity on survival outcomes of women with advanced epithelial ovarian cancer in Lagos, Nigeria: a retrospective cohort study.Ecancermedicalscience. 2024 Aug 20;18:1743. doi: 10.3332/ecancer.2024.1743. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39421179 Free PMC article.
-
Survival outcomes following interval versus primary debulking surgery in advanced epithelial ovarian cancer: A retrospective cohort study in Lagos, Southwest Nigeria.Res Sq [Preprint]. 2024 Jan 5:rs.3.rs-3834135. doi: 10.21203/rs.3.rs-3834135/v1. Res Sq. 2024. PMID: 38260667 Free PMC article. Preprint.
-
An Assessment of Ovarian Cancer Histotypes Across the African Diaspora.Front Oncol. 2021 Nov 26;11:732443. doi: 10.3389/fonc.2021.732443. eCollection 2021. Front Oncol. 2021. PMID: 34900682 Free PMC article.
-
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria.JCO Glob Oncol. 2021 Jan;7:89-98. doi: 10.1200/GO.20.00450. JCO Glob Oncol. 2021. PMID: 33449803 Free PMC article.
-
Preoperative Predictors of Optimal Tumor Resectability in Patients With Epithelial Ovarian Cancer.Cureus. 2022 Jan 19;14(1):e21409. doi: 10.7759/cureus.21409. eCollection 2022 Jan. Cureus. 2022. PMID: 35198316 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- Iyoke CA, Ugwu GO. Burden of gynaecological cancers in developing countries. World Obstet Gynaecol. 2013;2(1):1–7.
-
- Nkyekyer K. Pattern of gynaecological cancers in Ghana. East Afr Med J. 2000;77(10):534–8. - PubMed
-
- Ugwu EO, Iferikigwe ES, Okeke TC, Ugwu AO, Okezie OA, Agu PU. Pattern of gynaecological cancers in University of Nigeria Teaching Hospital, Enugu, South Eastern Nigeria. Niger J Med. 2011;20(2):266–9. - PubMed
-
- Buhari MO, Ojo BA, Ijaiya MA, Aboyeji PA. Ovarian cancers in Ilorin, Nigeria-a review of over 80 cases. Nig Q J Hosp Med. 2005;15(3):127–30.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical